RNU6-899P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU6-899P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6-899P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-899P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-899P expression acts as an unfavorable survival marker, although some lineages such as STAD and DLBC show a favorable association.

ACC, STAD, and LIHC are the cancer types where RNU6-899P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
ACCOSTertileAll0.1530.641.00257view →
STADDFSTertileIII,IV0.7230.538.00556view →
LIHCDFSTertileAll0.0760.535<.00136view →
CESCDFSTertileII,III,IV0.5730.809.00336view →
LGGOSTertileAll0.4620.818<.00127view →
THYMDFSTertileII,III,IV0.2270.800.00418view →
LAMLDFSTertileAll0.2130.595.03818view →
PCPGOSTertileAll0.5260.975<.00118view →
KIRCDFSTertileIII,IV0.2660.500.02415view →
THCAOSTertileIII,IV0.5850.888.00212view →
SARCDFSTertileAll0.1620.638.0029view →
SKCMDFSTertileIII,IV0.0760.269.0226view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

Exploration